189 related articles for article (PubMed ID: 34678604)
21. One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents.
Barghash RF; Eldehna WM; Kovalová M; Vojáčková V; Kryštof V; Abdel-Aziz HA
Eur J Med Chem; 2022 Jan; 227():113952. PubMed ID: 34731763
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and discovery of pyrazolo-pyridine analogs as inflammation medications through pro- and anti-inflammatory cytokine and COX-2 inhibition assessments.
Dennis Bilavendran J; Manikandan A; Thangarasu P; Sivakumar K
Bioorg Chem; 2020 Jan; 94():103484. PubMed ID: 31796215
[TBL] [Abstract][Full Text] [Related]
24. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.
Li N; Xin WY; Yao BR; Cong W; Wang CH; Hou GG
Eur J Med Chem; 2018 Jul; 155():531-544. PubMed ID: 29909338
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, toxicities and bio-activities of manganese complexes with CO and H
Bai Z; Zhang J; Zhang Q; Zhang T; Li J; Zhao Q; Wang Z; He D; Cheng J; Zhang J; Liu B
Eur J Med Chem; 2018 Nov; 159():339-356. PubMed ID: 30308409
[TBL] [Abstract][Full Text] [Related]
26. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
[TBL] [Abstract][Full Text] [Related]
27. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, docking and evaluation of in vitro anti-inflammatory activity of novel morpholine capped β-lactam derivatives.
Heiran R; Sepehri S; Jarrahpour A; Digiorgio C; Douafer H; Brunel JM; Gholami A; Riazimontazer E; Turos E
Bioorg Chem; 2020 Sep; 102():104091. PubMed ID: 32717692
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro Anti-Inflammatory Activity of Novel Dendrobine Amide/Sulfonamide Derivatives.
Jiao ZW; Liu HF; Lin KQ; Xie GT; Lou HY; Pan WD; Zhang MS
Chem Biodivers; 2024 May; 21(5):e202400030. PubMed ID: 38511964
[TBL] [Abstract][Full Text] [Related]
30. New arylpyrazoline-coumarins: Synthesis and anti-inflammatory activity.
Chen LZ; Sun WW; Bo L; Wang JQ; Xiu C; Tang WJ; Shi JB; Zhou HP; Liu XH
Eur J Med Chem; 2017 Sep; 138():170-181. PubMed ID: 28667873
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors.
Park A; Hwang J; Lee JY; Heo EJ; Na YJ; Kang S; Jeong KS; Kim KY; Shin SJ; Lee H
Bioorg Med Chem Lett; 2021 Sep; 47():128226. PubMed ID: 34182093
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis and Anticancer Profile of New 4-(1
Abdel-Maksoud MS; Mohamed AAB; Hassan RM; Abdelgawad MA; Chilingaryan G; Selim S; Abdel-Bakky MS; Al-Sanea MM
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638829
[TBL] [Abstract][Full Text] [Related]
33. Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies.
El Sayed MT; Hussein HAR; Elebiary NM; Hassan GS; Elmessery SM; Elsheakh AR; Nayel M; Abdel-Aziz HA
Bioorg Chem; 2018 Aug; 78():312-323. PubMed ID: 29625271
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro screening of phenylbipyridinylpyrazole derivatives as potential antiproliferative agents.
Al-Sanea MM; Elkamhawy A; Zakaria A; Park BS; Kwon Y; Lee SH; Lee SW; Kim IT
Molecules; 2015 Jan; 20(1):1031-45. PubMed ID: 25584833
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, in vitro anticancer activity and in silico studies of certain pyrazole-based derivatives as potential inhibitors of cyclin dependent kinases (CDKs).
Mohammed EZ; Mahmoud WR; George RF; Hassan GS; Omar FA; Georgey HH
Bioorg Chem; 2021 Nov; 116():105347. PubMed ID: 34555628
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of 4-(pyridine-4-oxy)-3-(tetrahydro-2H-pyran-4-yl)-pyrazole derivatives as novel, potent of ALK5 receptor inhibitors.
Wang Z; Zhang Y; Wang H; Wang X; Yu Z; Zhao L
Bioorg Med Chem Lett; 2022 Apr; 61():128552. PubMed ID: 35051574
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents.
Abdel-Aziz HA; Al-Rashood KA; ElTahir KE; Suddek GM
Eur J Med Chem; 2014 Jun; 80():416-22. PubMed ID: 24794773
[TBL] [Abstract][Full Text] [Related]
39. Discovery and optimization of tetrahydropyrido[4,3-d]pyrimidine derivatives as novel ATX and EGFR dual inhibitors.
Jing T; Miao X; Jiang F; Guo M; Xing L; Zhang J; Zuo D; Lei H; Zhai X
Bioorg Med Chem; 2018 May; 26(8):1784-1796. PubMed ID: 29496411
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]